AFM-Telethon is pleased to announce the launch of its first international call for proposals for Translational Research Projects on « A single therapeutic product for several mitochondrial disorders ». The MitoNice Congress, organized in September 2022 by the AFM-Telethon along with the 7 th International Myology Congress, highlighted that mitochondrial medicine has moved from the identification of the genes involved in mitochondrial diseases to the development of therapeutic options. To accelerate this progress towards therapeutic solutions for patients who urgently need it, this call is open to any research project on primary mitochondrial diseases that will develop a therapeutic approach targeting several mitochondrial diseases.
Scientific focus, application, and more information here (PDF).